Revive Therapeutics Announces $1M Private Placement
Revive Therapeutics (OTCQB:RVVTF) plans a private placement offering up to ~$1 million through the sale of units priced at $0.032 each, with proceeds intended for working capital.
More World news
- Jensen Huang Resigns as Nvidia CEO Amid Investigation into Foreign Intelligence Allegations
- SuperCom Reports Q3 Fiscal 2026 Earnings Beat on Revenue and EPS
- Marvell Technology Appoints Three Independent Directors Prior to Proposed Lumentum Acquisition
- M-tron Industries Reports Q3 2026 GAAP EPS Miss Amid Low Revenue
- Nexxen International Reports Q3 Earnings Beat with Revenue Growth and Increased EBITDA
- Brookfield Corporation Announces Quarterly Dividend of $0.07 Per Share
- Upwork Expands Restructuring Plan to Reduce Workforce by 37%
- Deswell Industries Reports First-Half Revenue of $33.02 Million Amid Segment Shifts
- Avicanna Reports Q3 Results with Positive Adjusted EBITDA and Reduced Operating Losses
- Bridgemarq Real Estate Services Announces Monthly Dividend of CAD 0.0125 per Share